Clinical trials
Phase 2 Acute Coronary Syndrome trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
64 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 3 |
| 2006 | 4 |
| 2007 | 6 |
| 2008 | 4 |
| 2009 | 5 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 4 |
| 2022 | 5 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 46 |
| Terminated | 6 |
| Recruiting | 5 |
| Unknown status | 5 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 3 |
| Cerenis Therapeutics, SA | 2 |
| Damanhour University | 2 |
| Johns Hopkins University | 2 |
| Shaanxi Micot Pharmaceutical Technology Co., Ltd. | 2 |
| University of Alabama at Birmingham | 2 |
| University of Texas Southwestern Medical Center | 2 |
| ARCA Biopharma, Inc. | 1 |
| Abcentra | 1 |
| Amosov National Institute of Cardiovascular Surgery | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acute Coronary Syndrome | 64 |
| Myocardial Infarction | 12 |
| Angina, Unstable | 7 |
| Coronary Artery Disease | 7 |
| Coronary Disease | 5 |
| Heart Diseases | 5 |
| ST Elevation Myocardial Infarction | 5 |
| Myocardial Ischemia | 4 |
| Atherosclerosis | 3 |
| Acute Kidney Injury | 2 |
Trials
Showing 1 to 25 of 64. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.